BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25912675)

  • 1. Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells.
    Barzalobre-Gerónimo R; Flores-López LA; Baiza-Gutman LA; Cruz M; García-Macedo R; Ávalos-Rodríguez A; Contreras-Ramos A; Díaz-Flores A; Ortega-Camarillo C
    Mol Cell Biochem; 2015 Jul; 405(1-2):257-64. PubMed ID: 25912675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt enhances Mdm2-mediated ubiquitination and degradation of p53.
    Ogawara Y; Kishishita S; Obata T; Isazawa Y; Suzuki T; Tanaka K; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Jun; 277(24):21843-50. PubMed ID: 11923280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2.
    Choy MK; Movassagh M; Bennett MR; Foo RS
    J Cell Physiol; 2010 Mar; 222(3):635-9. PubMed ID: 19950214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28-MDM2-p53 complexes and by preventing the ubiquitination and degradation of p53.
    Sun NK; Huang SL; Chien KY; Chao CC
    Biochem J; 2012 Jun; 444(2):303-14. PubMed ID: 22397410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of polyamines in p53-dependent apoptosis of intestinal epithelial cells.
    Bhattacharya S; Ray RM; Johnson LR
    Cell Signal; 2009 Apr; 21(4):509-22. PubMed ID: 19136059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2-p53 Pathway.
    Barrio E; Vecino R; Sánchez-Morán I; Rodríguez C; Suárez-Pindado A; Bolaños JP; Almeida A; Delgado-Esteban M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of Smooth Muscle 22α Protein Accelerates Senescence of Vascular Smooth Muscle Cells via Stabilization of p53 In Vitro and In Vivo.
    Miao SB; Xie XL; Yin YJ; Zhao LL; Zhang F; Shu YN; Chen R; Chen P; Dong LH; Lin YL; Lv P; Zhang DD; Nie X; Xue ZY; Han M
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1849-1859. PubMed ID: 28798142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
    Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
    Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
    J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 inhibition-mediated autophagy contributes to the pro-apoptotic effect of berberine in p53-null leukemic cells.
    Liu J; Zhu Z; Liu Y; Wei L; Li B; Mao F; Zhang J; Wang Y; Liu Y
    Life Sci; 2020 Feb; 242():117228. PubMed ID: 31881227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.
    Gajjar M; Candeias MM; Malbert-Colas L; Mazars A; Fujita J; Olivares-Illana V; Fåhraeus R
    Cancer Cell; 2012 Jan; 21(1):25-35. PubMed ID: 22264786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
    Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
    J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
    Dong C; Zhao B; Long F; Liu Y; Liu Z; Li S; Yang X; Sun D; Wang H; Liu Q; Liang R; Li Y; Gao Z; Shao S; Miao QR; Wang L
    Oncotarget; 2016 Feb; 7(8):8850-65. PubMed ID: 26840457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.
    Jin L; Li C; Xu Y; Wang L; Liu J; Wang D; Hong C; Jiang Z; Ma Y; Chen Q; Yu F
    Oncol Rep; 2013 May; 29(5):1983-90. PubMed ID: 23483203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
    Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
    Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High glucose induces mitochondrial p53 phosphorylation by p38 MAPK in pancreatic RINm5F cells.
    Flores-López LA; Díaz-Flores M; García-Macedo R; Ávalos-Rodríguez A; Vergara-Onofre M; Cruz M; Contreras-Ramos A; Konigsberg M; Ortega-Camarillo C
    Mol Biol Rep; 2013 Aug; 40(8):4947-58. PubMed ID: 23657598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.